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a  b  s  t  r  a  c  t
Inﬁltrating  lipomatosis  of  the  face  has been  described  as  a  congenital  disorder  in  which  mature  lipocytes
invade  adjacent  tissues  in the  facial  region.  The  presentation  is  always  unilateral  with  hypertrophy  of
hard  and  soft  structures  on  the  affected  side  of  the  face.  We  present  a case  of  a 27-year-old  female  who
reported with  a  complaint  of  recurrent  unilateral  facial  swelling  with  history  of  two  previous  resections,
the  histopathology  or  details  of these  surgeries  were  not  available.  The  patient  underwent  resection
of  tumour  and  the  histopathology  conﬁrmed  it to  be  inﬁltrating  lipomatosis.  The  surgery  resulted  in
a  deﬁnite  improvement  in  the facial  asymmetry  and  the patient  is  being  closely  followed  up with  no
evidence  of  recurrence.  The  pathogenesis  of  the  condition  is  unclear,  though  it  has  been postulated  that
the  condition  is  at one  end of a spectrum  of  overgrowth  syndromes  with  classic  Proteus  syndrome  onroteus syndrome the  other  extreme.  Management  of this  condition  involves  resection  of the  tumour  which  in  most  cases
is  subtotal  to reduce  the  risk  of  damage  to facial  nerve.  There  is  a  controversy  regarding  both  timing  and
extent of  resection  in  the  literature  and we  think  the  subtotal  resection  of  tumour  in  an  adolescent  or
older patient  can  give  good  aesthetic  outcome  without  compromising  facial  nerve  function.  However,
the patients  should  be  informed  about  high  rate  of recurrence  and  increase  risk  of  complications  with
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any  subsequent  surgery.
. Introduction
Inﬁltrating lipomatosis of the face (IL-F) was ﬁrst described
s a distinct clinical–pathologic entity by Slavin et al. in 1983
s a congenital disorder in which mature adipocytes/lipocytes
nvade adjacent tissue, hard and soft, in the facial region.1 All
ases reported in the literature have been of patients in the ﬁrst
hree decades of life, with most presenting in infancy with uni-
ateral swelling of the cheek or chin due to normal functioning but
ypertrophied tissues.1–16 This condition shows a wide phenotypic
ange1–16 and distinct histopathologic features.1 Even though the
ondition is clearly deﬁned as a clinical entity, the pathogenesis
nd biological behaviour remain uncertain.15 In the reported cases,
here is a lack of consensus on treatment strategy with respect
o the extent of resection and timing of surgery. Regardless of
anagement philosophy, all reported cases had uncertain prog-
osis with high rates of recurrence and variable post-op cosmetic
mprovement.1–16 Here we report a case of a recurrent left sided
welling in the upper two thirds of the face in a 27-year-old female,
ith a history of two previous resections in this region.. Presentation of case
A 27-year-old female presented with a left-sided facial swelling.
he was reported to have a slight swelling in the left side of face
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from an early age which increased insidiously and resulted in
marked facial asymmetry by the age of 17 years. She gave history of
surgery for the reduction of the facial asymmetry on two previous
occasions at 19 years and then at 23 years of age, with signiﬁcant
recurrence on both occasions. The histopathology report and details
of previous surgeries were not available.
Clinical examination showed hard bony lump over the left zygo-
matic arch with soft tissue swelling extending from the left temple
to the left cheek and intact facial nerve function (Fig. 1a and b).
Computed tomography showed, bony enlargement of left zygo-
matic arch with evidence of normal marrow extension into these
bony protuberances. There was  overgrowth of the fat within the
subcutaneous tissues overlying the left anterior face with inﬁltra-
tion into the masseteric space and left parapharyngeal space up to
the skull base. There was  evidence of tubular soft tissue within the
fat density, possibly vessels (Fig. 2a and b).
The tumour was debulked, in May  2009, via a unilateral coro-
nal ﬂap and rhytidectomy incision and involved left superﬁcial
parotidectomy, removal of the zygomatic arch and a subtotal exci-
sion of the tumour without damaging the facial nerve. On surgical
exposure, the tumour appeared to be unencapsulated fatty tis-
sue spread in a subcutaneous plane inﬁltrating the masseter, the
parotid and the zygomatic arch, which was grossly deformed.
Post-operatively, the surgery produced a signiﬁcant improve-
ment in her appearance and with the exception of neurapraxia
Open access under CC BY-NC-ND license.affecting the zygomatic branch of the VII nerve there were no other
immediate post-op complications. On one year post-operative fol-
low up, the patient was  happy with the outcome of the surgery,
the palsy of the zygomatic branch of the VII nerve had resolved and
cense.
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here was no evidence of recurrence. She continues to be monitored
n a yearly basis and is fully aware of the likelihood of recurrence
Fig. 3a and b).
Histopathologic examination revealed sheets of subcutaneous
nencapsulated mature adipose tissue with scant supporting
brovascular stroma with no evidence of atypia or malignancy.
his tissue was seen to inﬁltrate the parotid tissue which showed
rominent replacement of the glandular tissue by mature adipose
issue. The lobular architecture of the gland was largely preserved
lthough the interlobular septa were compressed in many places.
Fig. 2. (a) CT scan showing subcutaneous fatty overgrowth and(b) pre-op left lateral face photograph.
The tumour also inﬁltrated the zygomatic bone which showed a
mild degree of remodelling and encompassing prominently fatty
marrow surrounded by sheets of mature lipocytes and supporting
ﬁbrovascular stroma (Figs. 4 and 5).
3. DiscussionLipomatosis can refer to occurrence of either multiple lipomas
or diffuse, inﬁltrating but benign tumours of mature adipose tissue.
Enzinger and Weiss classiﬁed the lipomatosis into three different
 (b) CT scan showing enlargement of left zygomatic arch.
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ntities: symmetrical lipomatosis (usually in the neck), pelvic lipo-
atosis and diffuse lipomatosis of the limbs and trunks.17 This
lassiﬁcation failed to include facial lipomatosis.
Slavin et al. described the following characteristic histomorpho-
ogic ﬁndings: (1) inﬁltration of fat into adjacent soft tissue and
ypertrophy of the underlying skeleton; (2) absence of malignant
haracteristics; (3) absence of lipoblasts; (4) presence of ﬁbrous
lement; (5) increased number of vessels with unifocally thick-
ned muscular walls; and (6) increased number of nerve bundles
f variable size with focal ﬁbrosis.1
Reported phenotypic features of facial lipomatosis include
1) unilateral hypertrophy of soft tissues of the face, most
ommonly the cheek, with underlying fat inﬁltration and skele-
al overgrowth,1–16 (2) cutaneous capillary blush (usually after
esection),10 (3) macrodontia on the affected side,1,3,6,9,10 (4) abnor-
al  root formation,3 (5) early eruption of deciduous and permanent
Fig. 4. Histology slide showing inﬁltration into muscle.(b) post-op left lateral face photograph.
teeth on the affected side,10,15,16 (6) macroglossia10,14,16 and (7)
protuberances on the tongue and buccal mucosa, which are repre-
sentation of underlying mucosal neuromas10,16 (Table 1).
The pathogenesis of IL-F is unclear. Based on commonality of
hamartomatous overgrowth of various tissues including fat, it has
been postulated that IL-F, represents one end of a spectrum of
disorders that includes at the other extreme classical Proteus syn-
drome. Proteus syndrome is characterised by sporadic occurrence,
verrucous epidermal nevi, variable benign tumours including lipo-
mas, vascular malformations and hyperostosis.18 The molecular
basis of Proteus syndrome is unclear but it has been postulated
to arise through embryonic somatic mutations resulting in somatic
19mosaicism. The variability in the phenotype would arise through
variability in the timing of the somatic mutation and distribution
of cells carrying the mutation. However, more recently some cases
of Proteus (10–20%) and Proteus-like (80%) syndrome have been
Fig. 5. Histology slide showing inﬁltration into bone.
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Table 1
Phenotypic features and recurrence in patients with Facial Inﬁltrating Lipomatosis reported within reviewed literature.
Author (s) Year Gender Age
(years)
Recurrence Phenotypic features
Slavin et al.1 1983 M 2 Yes Unilateral diffuse soft mass over parotid region.
F 9  No Unilateral swelling of soft tissue extending from cheek up
to  the temporal region with hypertrophy of underlying
zygoma.
F  2 Yes Unilateral diffuse mass over anterior maxilla extending to
the lower lip, periorbital and frontal regions.
De  Rosa et al.2 1987 M 53 Yes Unilateral hypertrophy of soft tissues of cheek and
underlying bone.
F  9 Yes Unilateral hypertrophy of soft tissues of cheek.
F  23 Yes Unilateral hypertrophy of soft tissue in submandibular
region, ﬂoor of mouth, lower lip and underlying
mandibular bone.
MacMillan et al.3 1990 F 36 Yes Unilateral diffuse swelling with hypertrophy of soft tissues
and underlying bone in the cheek and hypertrophy of soft
tissue in the affected side on the palate. Macrodontia of
maxillary teeth noted.
Donati et al.4 1990 M <1 No Unilateral hypertrophy of soft tissues of the cheek and
underlying bone.
Patel  and Gondalino5 1991 F <1 Not known Not known.
Kang et al.6 1998 M 25 No Unilateral hypertrophy of soft tissue and hard tissues of
cheek and macrodontia on the affected side.
Van  Wingerden et al.7 1998 M <2 Not known Not known.
Görken et al.8 1999 F 6 No Unilateral hypertrophy of soft tissues and bone in the
anterior maxillary region with multiple, pigmented
epithelial polyps and sebaceous nevi.
Bouletreau et al.9 2000 F 16 No Unilateral hypertrophy of soft tissue and hard tissues of
cheek with macrodontia on affected side.
Padwa and Mulliken10 2001 M (8)
F (5)
(n = 13)
Avg.
12.4
Range
1.1–22.9
In 6 cases Unilateral hypertrophy of cheek (12) and chin (1) with
underlying fat inﬁltration and skeletal overgrowth (9)
Cutaneous capillary blush (9)
Ipsilateral macroglossia (8)
Mucosal neuromas (6)
Early eruption of ipsilateral dentition (12)
Ergün  et al.11 2001 M 6 No Unilateral hypertrophy of cheek and ipsilateral upper lip.
M  45 No Unilateral hypertrophy of submental and submandibular
tissues including ipsilateral cortical expansion of mandible.
Chen  et al.12 2002 F <1 No Unilateral hypertrophy of cheek and ipsilateral upper lip.
Unal  et al.13 2003 F 2 No Unilateral diffuse soft mass on cheek.
Pires  Fraga et al.14 2008 M 2 Yes Unilateral diffuse soft tissue swelling on the lower
medium-third of the hemi-face extending to oral cavity,
the ﬂoor of mouth and the tongue on affected side.
Kamal  et al.15 2010 F 16 Not known Unilateral soft diffuse mass in the cheek extending from
lower border of mandible, to the inferior orbital rim, to the
oral commisure. Hemimandibular hypertrophy,
acceleration of dentoskeletal growth, macrodontia and
hypertrophy of the zygomatic bone.
F  18 Not known Unilateral mass on the left side of the face extending up to
the  temporal area associated with the hypertrophy of the
underlying zygoma.
M  2 NA (not operated
on)
Unilateral diffuse soft mass located on anterior maxilla
extending to the inferior orbital rim, lower border of
mandible and parotid gland region. Unilateral
macrodontia.
Kim  et al.16 2010 F 3.5 Yes Unilateral swelling of cheek, tongue, teeth, mandible,
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mhown to have germline mutations of the PTEN gene.19 The lack of
TEN mutations in many cases of Proteus syndrome indicates that
here is genetic heterogeneity in phenotypes deﬁned as Proteus
yndrome. Germline mutations in PTEN and RET (which is mutated
n multiple endocrine neoplasia type 2b) have been excluded in one
eries of IF-L.10
Interestingly, in two separate case reports cytomegalovirus
CMV) inclusions within the secretory cells of the parotid glands,
hich were inﬁltrated by lipomatous tumour, were found. How-
ver, it was not clear whether there was a causal relationship
etween the CMV  and lipomatosis.4,5
Differential diagnosis for non-acute unilateral facial enlarge-
ent includes infections, trauma, vascular malformations, benignparotid and submandibular salivary glands. Premature
eruption of secondary dentition, hyperplastic papillae of
the anterior third of tongue and mucosal neuromas.
and malignant tumours of soft and hard tissues. Amongst these
the possibility of hamartomatous or overgrowth syndromes should
also be considered.
Progression of the condition seems to follow two patterns: a
rapidly progressive form with extensive hypertrophy occurring
in early childhood (age < 1 year) and a more indolent form with
hypertrophy occurring over decades, with patients presenting for
treatment in adulthood.6 Management would therefore depend on
deciding the timing and extent of surgical excision.On review of literature, there is disagreement on this matter.
Early reports like Slavin et al. and Kang et al. recommended wide
and early local excision to prevent extensive inﬁltration.1,6 In con-
trast, Von Wingerden et al. suggest that by delaying resection, both
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he chance of damaging the facial nerve and the number of debulk-
ng procedures would diminish.7 They proposed liposuction for
chieving facial symmetry at an early stage of the disease instead
f an attempt at total excision.
There are others who favour a more conservative approach
ecause the tumour is benign in nature and has a critical location.3
More recently, Kamal et al. echoing the thoughts of Van Winger-
en et al., believe that no surgical procedures should be performed
ntil the end of the facial growth period and mention that the delay
f deﬁnitive surgery has other advantages such as minimising the
hance of damage to the facial nerve, decreasing the total number
f procedures, and having a mature contralateral cheek contour to
atch.15
Padwa and Mulliken believe growth hormones may  have a role
n recurrences and that any mass reduction before the end of ado-
escence is likely to fail.10 Waiting for the facial growth to stop may
ot always be acceptable to the patient’s family and the patient’s
sychosocial aspect should also be kept in mind.6,10 Proponents of
elayed surgical resection also noted that postponement may  make
he procedure more extensive.7
. Conclusion
Pathogenesis of inﬁltrating lipomatosis of the face is not fully
nderstood. The review of literature supports the fact that the con-
ition has a varied phenotype and that it is a congenital condition
ith an early (ﬁrst decade) presentation. Only 7 out of 36 reported
ases, presented in and beyond the second decade of life (Table 1).
Management of the condition is controversial, with varying
deas on the extent and timing of surgery. Resection in most
nstances is subtotal due to the inﬁltration of tumour into adjacent
oft and hard tissues and the location increasing the likelihood of
ompromising facial nerve function.
Incomplete excision is most likely to cause re-growth, which
s some believe is more likely if the patient is below the age of
dolescence.10,15 Restoration of full facial symmetry is unlikely, the
atient should also be informed about the high rate of recurrence
nd that surgery is accompanied by a high complication rate.
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